BioServe and NGC Medical SpA Launch BioServe-Europe
BioServe-Europe provides comprehensive pre-clinical molecular services and biospecimens to European life science researchers
"The combination of cutting edge genomic services and high-quality biosamples has proven to be a powerful offering for the scientific community in North America. Our recent foray in the EU market, working with NGC Medical, has revealed a similar strong demand for these unique services," said Rama Modali, President, BioServe.
Modali added, "The EU market is also quickly adopting new in-vitro diagnostic tests as part of a move to a personalized medicine regime. BioServe-Europe's genomic services have the ability to a key component in the processing and validation of these tests' results."
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.